1. Home
  2. CNTN vs TSI Comparison

CNTN vs TSI Comparison

Compare CNTN & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.84

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Logo TCW Strategic Income Fund Inc.

TSI

TCW Strategic Income Fund Inc.

HOLD

Current Price

$4.49

Market Cap

219.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNTN
TSI
Founded
2017
1987
Country
United States
United States
Employees
12
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
185.3M
219.6M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
CNTN
TSI
Price
$2.84
$4.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
110.6K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
7.46%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.14
$4.43
52 Week High
$5.27
$5.06

Technical Indicators

Market Signals
Indicator
CNTN
TSI
Relative Strength Index (RSI) 46.09 47.54
Support Level $2.14 $4.43
Resistance Level $3.80 $4.58
Average True Range (ATR) 0.31 0.04
MACD -0.01 0.00
Stochastic Oscillator 19.83 30.77

Price Performance

Historical Comparison
CNTN
TSI

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a diversified closed-end management investment company. The investment objective of the company is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as banks, beverages, biotechnology, chemicals, commercial services, and others.

Share on Social Networks: